Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?

• Main Authors: Monica D. Levine (Author), David M. O'Malley (Author), Paulina J. Haight (Author), Leigha Senter (Author), Vincent Wagner (Author), Kristin L. Bixel (Author), David E. Cohn (Author), Larry J. Copeland (Author), Casey M. Cosgrove (Author), Eric M. McLaughlin (Author), Floor J. Backes (Author)
• Format: Book
• Published: Elsevier, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: To determine the recurrence rate and survival among early-stage epithelial ovarian cancer cases considering homologous recombination deficiency (HRD) status. Methods: Single institution retrospective study of stage I/II EOC patients from 2017 to 2020. HRD was defined as evidence of germli...